NCT04301674 is a clinical trial of Breath Biopsy in Asthma, Occupational, sponsored by Oslo University Hospital.

Who is sponsoring NCT04301674?

NCT04301674 is sponsored by Oslo University Hospital.

What drugs are being tested in NCT04301674?

Interventions in NCT04301674: Breath Biopsy.

What condition does NCT04301674 study?

NCT04301674 studies Asthma, Occupational.

Is NCT04301674 still recruiting?

NCT04301674 is currently status unknown. Last updated 24 August 2022.

Last reviewed 2022-08-24 · How we verify

NCT04301674

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Metabolomics in Occupational Asthma

Status unknown Last updated 24 August 2022

What this trial tests

trial testing Breath Biopsy in Asthma, Occupational in 80 participants. Status unknown.

Timeline

15 October 2021

Primary endpoint
31 December 2022

1 June 2023

Quick facts

Lead sponsor	Oslo University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	80
Start date	15 October 2021
Primary completion	31 December 2022
Estimated completion	1 June 2023
Sites	1 location across Norway

Drugs / interventions tested

Breath Biopsy

Conditions studied

Asthma, Occupational — all drugs for Asthma, Occupational →

Sponsor

Oslo University Hospital

Who can join

18 and older, any sex, with Asthma, Occupational. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The project aims to increase the diagnostic accuracy in occupational asthma (OA), with emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in occupational medicine by comparing the exposure and symptom characteristics with epidemiological data. Biological markers may be present in AA, but presently not in IIA. The majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures. VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd, UK).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Breath Biopsy

Trials testing the same drug.

NCT04326491 — The Utility of Breath Biopsy as a Screening Tool for HCC · completed
NCT04602871 — Early Detection of COVID-19 Using Breath Analysis - Feasibility Study · NA · completed

Other Oslo University Hospital trials

Trials by the same sponsor.

NCT07463885 — Spontaneous vs Controlled Mechanical Ventilation in Acute Hypoxemic Respiratory Failure · NA · not yet recruiting
NCT07427719 — Retinopathy of Prematurity - Visual Function and Retinal Structure · not yet recruiting
NCT07403331 — Severe Chronic Neuropathic Pain: A Treatment Bundle, Using Spinal Cord Stimulation and Multidisciplinary Treatment, to R · NA · recruiting
NCT07449897 — Cholecystectomy With Intraoperative Management of Bile Duct Stones in Norway - the BILNOR Study · recruiting
NCT06173817 — The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients · Phase 1 · withdrawn

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04301674 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Oslo University Hospital
Last refreshed: 24 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04301674.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing